LNSR Q3 2025 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+5.7% YoY

Gross Profit

$6M40.6% margin

Operating Income

-$8M-52.9% margin

Net Income

-$4M-25.9% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$850,000

Balance Sheet

Total Assets

$70M

Total Liabilities

$82M

Stockholders' Equity

-$12M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$14M	+5.7%
Gross Profit	$6M	$6M	-7.3%
Operating Income	-$8M	-$1M	-648.3%
Net Income	-$4M	-$2M	-147.2%

Revenue Segments

Product

$11M89%

Service

$1M11%

Geographic Segments

UNITED STATES

$9M68%

Europe

$2M18%

Asia Excluding South Korea

$2M12%

KOREA, REPUBLIC OF

$183,0001%

Other Geographical Region

$41,0000%